155 related articles for article (PubMed ID: 10669851)
21. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
[TBL] [Abstract][Full Text] [Related]
22. Alloantigen-reactive Th1 development in IL-12-deficient mice.
Piccotti JR; Li K; Chan SY; Ferrante J; Magram J; Eichwald EJ; Bishop DK
J Immunol; 1998 Feb; 160(3):1132-8. PubMed ID: 9570526
[TBL] [Abstract][Full Text] [Related]
23. Regulatory function of CpG-activated B cells in late-phase experimental allergic conjunctivitis.
Miyazaki D; Kuo CH; Tominaga T; Inoue Y; Ono SJ
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1626-35. PubMed ID: 19060266
[TBL] [Abstract][Full Text] [Related]
24. A novel murine model of allergic conjunctivitis.
Magone MT; Chan CC; Rizzo LV; Kozhich AT; Whitcup SM
Clin Immunol Immunopathol; 1998 Apr; 87(1):75-84. PubMed ID: 9576013
[TBL] [Abstract][Full Text] [Related]
25. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
[TBL] [Abstract][Full Text] [Related]
26. IFN-gamma is necessary but not sufficient for anti-CD40 antibody-mediated inhibition of the Th2 response to Schistosoma mansoni eggs.
Martin DL; King CL; Pearlman E; Strine E; Heinzel FP
J Immunol; 2000 Jan; 164(2):779-85. PubMed ID: 10623823
[TBL] [Abstract][Full Text] [Related]
27. Soluble P-selectin glycoprotein ligand 1 inhibits ocular inflammation in a murine model of allergy.
Strauss EC; Larson KA; Brenneise I; Foster CS; Larsen GR; Lee NA; Lee JJ
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1336-42. PubMed ID: 10359314
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling.
Behera AK; Kumar M; Lockey RF; Mohapatra SS
Hum Gene Ther; 2002 Sep; 13(14):1697-709. PubMed ID: 12396623
[TBL] [Abstract][Full Text] [Related]
29. Inducing ocular allergy with beta-lactoglobulin: a new experimental model.
Sari A; Dinc E; Yilmaz BC; Adiguzel U; Oztuna S; Tasdelen B
Ophthalmic Res; 2010; 44(2):119-24. PubMed ID: 20523103
[TBL] [Abstract][Full Text] [Related]
30. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
31. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
[TBL] [Abstract][Full Text] [Related]
32. Roles of Epithelial Cell-Derived Type 2-Initiating Cytokines in Experimental Allergic Conjunctivitis.
Asada Y; Nakae S; Ishida W; Hori K; Sugita J; Sudo K; Fukuda K; Fukushima A; Suto H; Murakami A; Saito H; Ebihara N; Matsuda A
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5194-202. PubMed ID: 26244295
[TBL] [Abstract][Full Text] [Related]
33. PAS-1, a protein from Ascaris suum, modulates allergic inflammation via IL-10 and IFN-gamma, but not IL-12.
Araújo CA; Perini A; Martins MA; Macedo MS; Macedo-Soares MF
Cytokine; 2008 Dec; 44(3):335-41. PubMed ID: 19008120
[TBL] [Abstract][Full Text] [Related]
34. Gamma interferon (IFN-gamma) and IFN-gamma-inducing cytokines interleukin-12 (IL-12) and IL-18 do not augment infection-stimulated bone resorption in vivo.
Sasaki H; Balto K; Kawashima N; Eastcott J; Hoshino K; Akira S; Stashenko P
Clin Diagn Lab Immunol; 2004 Jan; 11(1):106-10. PubMed ID: 14715554
[TBL] [Abstract][Full Text] [Related]
35. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis.
Matsuba-Kitamura S; Yoshimoto T; Yasuda K; Futatsugi-Yumikura S; Taki Y; Muto T; Ikeda T; Mimura O; Nakanishi K
Int Immunol; 2010 Jun; 22(6):479-89. PubMed ID: 20501612
[TBL] [Abstract][Full Text] [Related]
36. A critical role of IL-33 in experimental allergic rhinitis.
Haenuki Y; Matsushita K; Futatsugi-Yumikura S; Ishii KJ; Kawagoe T; Imoto Y; Fujieda S; Yasuda M; Hisa Y; Akira S; Nakanishi K; Yoshimoto T
J Allergy Clin Immunol; 2012 Jul; 130(1):184-94.e11. PubMed ID: 22460070
[TBL] [Abstract][Full Text] [Related]
37. Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Mittler RS; Yagita H; Ueno H
J Immunol; 2005 Oct; 175(8):4897-903. PubMed ID: 16210591
[TBL] [Abstract][Full Text] [Related]
38. The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgE-mediated allergic conjunctivitis.
Fukuda K; Kuo CH; Morohoshi K; Liu FT; Ono SJ
Br J Ophthalmol; 2012 Aug; 96(8):1132-6. PubMed ID: 22694967
[TBL] [Abstract][Full Text] [Related]
39. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
Galatowicz G; Ajayi Y; Stern ME; Calder VL
Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
[TBL] [Abstract][Full Text] [Related]
40. Development of an animal model for allergic conjunctivitis: influence of genetic factors and allergen concentration on immune response.
Giavina-Bianchi P; Kalil J; Rizzo LV
Acta Ophthalmol; 2008 Sep; 86(6):670-5. PubMed ID: 18752518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
